Literature DB >> 8172186

Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence?

M Harvey, D Rosenfeld, D Davies, B M Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172186     DOI: 10.1002/ajh.2830460220

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency.

Authors:  Stefano Vavassori; Janet Chou; Laura Eva Faletti; Veronika Haunerdinger; Lennart Opitz; Pascal Joset; Christopher J Fraser; Seraina Prader; Xianfei Gao; Luise A Schuch; Matias Wagner; Julia Hoefele; Maria Elena Maccari; Ying Zhu; George Elakis; Michael T Gabbett; Maria Forstner; Heymut Omran; Thomas Kaiser; Christina Kessler; Heike Olbrich; Patrick Frosk; Abduarahman Almutairi; Craig D Platt; Megan Elkins; Sabrina Weeks; Tamar Rubin; Raquel Planas; Tommaso Marchetti; Danil Koovely; Verena Klämbt; Neveen A Soliman; Sandra von Hardenberg; Christian Klemann; Ulrich Baumann; Dominic Lenz; Andreas Klein-Franke; Martin Schwemmle; Michael Huber; Ekkehard Sturm; Steffen Hartleif; Karsten Häffner; Charlotte Gimpel; Barbara Brotschi; Guido Laube; Tayfun Güngör; Michael F Buckley; Raimund Kottke; Christian Staufner; Friedhelm Hildebrandt; Simone Reu-Hofer; Solange Moll; Achim Weber; Hundeep Kaur; Stephan Ehl; Sebastian Hiller; Raif Geha; Tony Roscioli; Matthias Griese; Jana Pachlopnik Schmid
Journal:  J Allergy Clin Immunol       Date:  2021-04-17       Impact factor: 10.793

3.  Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.

Authors:  Julien Mahe; Aurélie Meurette; Anne Moreau; Caroline Vercel; Pascale Jolliet
Journal:  Drug Des Devel Ther       Date:  2013-08-07       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.